Thomas Ybert, DNA Script CEO (Eric Piermont/AFP via Getty Images)
Backed by Eli Casdin, a DNA synthesis company gets a big Series C ahead of its first product launch
An Eli Casdin-backed company looking to shake up the business of DNA printing clinched a nine-figure raise to get its first product off the ground …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
